echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > JE: Study on the mechanism of Fuzheng Xiaozheng Recipe in alleviating liver cancer in rats

    JE: Study on the mechanism of Fuzheng Xiaozheng Recipe in alleviating liver cancer in rats

    • Last Update: 2021-12-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Fuzhengxiaozhen disease square by the Ming Dynasty "plague of" famous decoction recorded three scattered derived from traditional Chinese medicine, after years of clinical application, Fuzhengxiaozhen disease parties that have struck in cirrhosis and hepatocellular carcinoma (HCC) therapy Satisfactory results
    .


    However, its underlying mechanism is still largely unknown


    Fuzheng Xiaozheng Recipe Fuzheng Xiaozheng Recipe "On Epidemic Disease " "On Epidemic Disease " Sanjia San Sanjia San

    A study recently published in the Journal of Ethnopharmacology, the use of diethylnitrosamine (DEN) to induce hepatocellular carcinoma in rats, and treatment with Fuzheng Xiaozheng Decoction aims to systematically evaluate the effects of Fuzheng Xiaozheng Decoction on rats The intervention effect of HCC, and in-depth elucidation of its regulatory mechanism
    .

    The study used high performance liquid chromatography (HPLC) to analyze the ingredients of the prepared medicine
    .


    Blood biochemistry (ALT, AST, ALP, GGT, DBIL, TBIL), liver histopathology, and immunohistochemistry (Ki67) were used to evaluate the intervention effect


    High-performance liquid chromatography (HPLC) analysis of the prepared pharmaceutical ingredients High-performance liquid chromatography (HPLC) analysis of the prepared pharmaceutical ingredients miRNA-Seq and mRNA-Seq miRNA-Seq and mRNA-Seq regulation mechanism regulation mechanism

    The study identified 9 potential ingredients from Fuzheng Xiaozheng Recipe , and its anti-cancer predictions showed that almost all ingredients showed anti-cancer effects
    .

    9 potential ingredients 9 potential ingredients

    H&E staining showed that the model group had obvious inflammation infiltration, the volume of hepatocytes was reduced , and the liver pathology of the treatment group was significantly improved
    .


    In addition, Ki67 immunohistochemistry also showed that the proliferation and differentiation of liver cancer cells in the treatment group was lower than that in the model group, and the proportion of Ki67+ cells in the treatment group was significantly lower than that in the model group


    The model group has obvious inflammation infiltration, and the hepatocyte volume is reduced.


    PPAR signaling pathway, arachidonic acid metabolism, bile secretion PPAR signaling pathway, arachidonic acid metabolism, bile secretion

    The QRT-PCR results showed that among the 4 DEmiRs, 3 expressed consistent with miRNA-Seq, and the 6 selected mRNAs all showed the same expression trend as mRNA-Seq
    .


    Both qRT-PCR and RNA-Seq showed that the expression trend of this gene was dose-dependent, which was consistent with the above results


    In order to further confirm the regulating effect of Fuzheng Xiaozheng Recipe on lipid-related metabolism and inflammation, the study detected the contents of 4 lipid-related indexes (TC, TG, LDL-C, HDL-C) and 4 kinds of cells in the serum.
    The expression level of factors (IL-2, IL-6, IL-10, IFN-γ)
    .


    After the intervention of Fuzheng Xiaozheng Recipe, TC and TG showed a downward trend from the model group to the high-dose treatment group, and the contents of LDL-C and HDL-C showed an upward trend


    (TC, TG, LDL-C, HDL-C) (TC, TG, LDL-C, HDL-C) (IL-2, IL-6, IL-10, IFN-γ) (IL-2, IL- 6.


    Regulate lipid-related metabolism and enhance anti-inflammatory ability Regulate lipid-related metabolism and enhance anti-inflammatory ability

     

    Literature source:

    Literature source:

    Li Xia.


    Li Xia.
    , Yu Han.
    , Gong Yanju.
    , Wu Peijie.
    , Feng Quan-Sheng.
    , Liu Chao.
    (2021).
    Fuzheng Xiaozheng prescription relieves rat hepatocellular carcinoma through improving anti-inflammation capacity and regulating lipid related metabolisms.
    J Ethnopharmacol , undefined(undefined), 114801.
    doi:10.
    1016/j.
    jep.
    2021.
    114801 leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.